Mennerick S, Dhond R P, Benz A, Xu W, Rothstein J D, Danbolt N C, Isenberg K E, Zorumski C F
Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri 63110, USA.
J Neurosci. 1998 Jun 15;18(12):4490-9. doi: 10.1523/JNEUROSCI.18-12-04490.1998.
To address the question of the relative contributions of glial and neuronal glutamate transport in the vertebrate CNS, we studied the distribution of forebrain glutamate transporters in rat hippocampal microcultures, a preparation in which physiological functions of glutamate transporters have been well characterized. Two of the three transporters, GLAST (EAAT1) and EAAC1 (EAAT3), are localized to microculture glia and neurons, respectively, as expected. However, we find strong immunoreactivity for the third glutamate transporter GLT-1 (EAAT2), a putatively glial transporter, in microculture neurons and in a small subset of microculture glia. Indistinguishable immunohistochemical staining patterns for GLT-1 were obtained with antibodies directed against both the N terminal and C terminal of the GLT-1 protein. Double-labeling experiments suggest that neuronal GLT-1 protein is primarily localized to the dendrites of excitatory neurons. Neuronal electrogenic transport currents in response to D-aspartate applications were occluded by the selective GLT-1 inhibitor dihydrokainate. In contrast, glia exhibited a larger transporter current density than did neurons, and the glial transport current was less sensitive to dihydrokainate. Neuronal transport currents were potentiated less than were glial currents when the chaotropic anion thiocyanate was substituted for gluconate in the whole-cell recording pipette, consistent with the previously reported lower anion permeability of EAAC1 and GLT-1 compared with that of GLAST. After microculture glia were rendered nonviable, excitatory autaptic currents (EACs) were prolonged in the presence of dihydrokainate, suggesting that neuronal GLT-1 is capable of participating in the clearance of synaptically released glutamate. Our results suggest that the initially proposed characterization of GLT-1 as a purely glial transporter is too simplistic and that under certain conditions functional GLT-1 protein can be expressed in brain neurons. The study suggests that changes in GLT-1 levels that occur with pathology or experimental manipulations cannot be assumed to be glial.
为了解决脊椎动物中枢神经系统中胶质细胞和神经元谷氨酸转运的相对贡献问题,我们研究了大鼠海马微培养物中前脑谷氨酸转运体的分布,在这种制备物中,谷氨酸转运体的生理功能已得到充分表征。正如预期的那样,三种转运体中的两种,即谷氨酸转运体1(GLAST,兴奋性氨基酸转运体1)和兴奋性氨基酸载体1(EAAC1,兴奋性氨基酸转运体3),分别定位于微培养的胶质细胞和神经元。然而,我们发现第三种谷氨酸转运体谷氨酸转运体-1(GLT-1,兴奋性氨基酸转运体2),一种推测为胶质细胞的转运体,在微培养的神经元和一小部分微培养的胶质细胞中具有强烈的免疫反应性。用针对GLT-1蛋白N端和C端的抗体获得了无法区分的GLT-1免疫组织化学染色模式。双重标记实验表明,神经元GLT-1蛋白主要定位于兴奋性神经元的树突。选择性GLT-1抑制剂二氢海因酸盐可阻断对D-天冬氨酸应用产生的神经元电生性转运电流。相比之下,胶质细胞表现出比神经元更大的转运体电流密度,并且胶质细胞的转运电流对二氢海因酸盐的敏感性较低。当在全细胞记录移液管中用离液序列高的阴离子硫氰酸盐替代葡萄糖酸盐时,神经元转运电流的增强小于胶质细胞电流,这与先前报道的EAAC1和GLT-1与GLAST相比具有较低的阴离子通透性一致。在微培养的胶质细胞失去活力后,在二氢海因酸盐存在的情况下,兴奋性自突触电流(EACs)延长,这表明神经元GLT-1能够参与清除突触释放的谷氨酸。我们的结果表明,最初将GLT-1描述为纯粹的胶质细胞转运体过于简单,并且在某些条件下,功能性GLT-1蛋白可以在脑神经元中表达。该研究表明,在病理或实验操作中发生的GLT-1水平变化不能被认为是胶质细胞性的。